RBR-87kphy
Completed
未知
Efficacy and safety of topical 0,2% Thiamidol versus 4% Hydroquinone in the treatment of facial Melasma in women: a randomized and evaluator blinded clinical trial
Faculdade de Medicina de Botucatu (FMB - Unesp)0 sitesStarted: October 9, 2020Last updated:
ConditionsMelasma
Overview
- Phase
- 未知
- Status
- Completed
- Sponsor
- Faculdade de Medicina de Botucatu (FMB - Unesp)
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Intervention
Eligibility Criteria
- Ages
- 18Y to 50Y (—)
- Sex
- Female
Inclusion Criteria
- •Women with facial melasma 18 to 50 years old, Fitzpatrick's phototypes II to V.
Exclusion Criteria
- •Pregnant and lactating women; women with vitiligo or photosensitizing diseases; individuals who are using other whitening substances and those who refuse to be photographed; photoexposed women and menopausal women (after 50 years).
Investigators
Similar Trials
Recruiting
Phase 1
Efficacy and safety of 0.15% Thiamidol combination with hyaluronic acid versus 0.15%Thiamidol or hyaluronic acid alone in treatment of melasma : A randomized single-blind trialMelasma is acquired light to dark-brown poorly circumscribed maculees. It's mainly seen in premenopausal women. The etiology of melasma is the combination of genetic,hormonal and ultraviolet light exmelasmaTCTR20200710001Faculty of medicine, Thammasat university96
Recruiting
Phase 3
The efficacy and safety of 0.5% topical timolol on corneometry and transepidermal water loss after ablative fractional CO2 laser for atrophic acne scars: a split face randomized double blind placebo-controlled trialWe considered that timolol may have an effect in wound healing promotion in patients who undergo AFCO2 resurfacing. Our study aimed to investigate the efficacy and safety of 0.5% topical timolol maleaTCTR20190722005none25
Recruiting
Phase 2
Evaluation of efficacy of Topical Timolol for treatment in conjunctival Pyogenic GranulomPyogenic granuloma.Pyogenic granulomaL98.0IRCT20160523028008N27Hamedan University of Medical Sciences46
Active, not recruiting
Phase 1
Study to evaluate efficacy and safety of topical administration of timolol maleate 0.5% solution in the treatment of Child Proliferative Hemangioma Early Stage SurfaceChildren Superficial HemangiomaTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]EUCTR2013-005199-17-ESInstitut de Recerca HSCSP70
Not yet recruiting
Not Applicable
To test the effectiveness of two commonly used medicines in Oral Lichen Planus and to study their molecular interactions.Health Condition 1: K00-K14- Diseases of oral cavity and salivary glandsCTRI/2023/08/056156MGM Dental College and Hospital